NASDAQ:XLRN
Delisted
Acceleron Pharma Inc. Stock News
$178.75
+0 (+0%)
At Close: May 27, 2022
Acceleron Pharma (XLRN) Reports Q3 Loss, Lags Revenue Estimates
06:15pm, Thursday, 05'th Nov 2020
Acceleron (XLRN) delivered earnings and revenue surprises of -20.00% and -17.51%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?